Resalis Therapeutics
Treatments for metabolic diseases
Resalis Therapeutics has raised €20M across 2 funding rounds from 5 investors, most recently a Series A round in Jan 2024. Based in Turin, Italy; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€20M
€20,000,000
Funding rounds
2
Investors
5
distinct backers
Active since
2023-02
latest 2024-01
Funding by year
EUR raised per yearResalis Therapeutics — funding by year — interactive chart.
Data table
| Resalis Therapeutics — funding by year | |
|---|---|
| 2023 | €10M |
| 2024 | €10M |
Signals
High confidenceRaise-next likelihood18
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds- 2024-01-04Series A€10MAngel Investors,Claris Ventures,Sunstone Life Science Ventures
- 2023-02-22Seed€10M
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-04 | Series A | €10M | Angel Investors,Claris Ventures,Sunstone Life Science Ventures | View deal → |
| 2023-02-22 | Seed | €10M | Claris Ventures,Italian Angels for Growth,Pietro Puglisi | View deal → |
Investors
5Related news
- Resalis Therapeutics Raises €10M in Seed Financingfinsmes.com · 2023-02
- eu-startups.com
Similar companies
same sector, similar size- 1000Farmacie€22MItaly · Healthtech
- Sibylla Biotech€23MItaly · Healthtech
- Unobravo€17MItaly · Healthtech
- Serenis€12MItaly · Healthtech
- Genespire€16MItaly · Healthtech
- Tensive€21MItaly · Healthtech
Global coverage: FundingData